Company Overview and News

 
Market Live: Sensex near day#39;s high, Midcap outperforms; Vedanta under pressure

2018-05-25 moneycontrol
Market Update: The market held on to morning gains, with the Sensex rising around 150 points while the Nifty Midcap index extended rally, rising nearly 1.5 percent.

 
Market Live: Sensex, Nifty rangebound; rupee hits fresh 16-month low

2018-05-23 moneycontrol
IMD on Monsoon: India Meteorological Department said it did not see possibility of El Nino this year.

 
Market Live: Sensex under pressure; SBI lifts PSU Bank over 3%, metals lose shine

2018-05-23 moneycontrol
Market Update: The market remained mildly under pressure, with the Nifty falling below the 10,500 levels following weakness in global stocks.

 
JM Financial Limited - Press Release

2018-05-23 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Podcast | Takeover battle for Fortis over as Munjal-Burmans bid gets a nod?

2018-05-11 moneycontrol
There seems to be an end in sight for the month-and-a-half long bidding war between multiple parties from different countries wishing to acquire Fortis. The winning bid which now belongs to Sunil Munjal and the Burman family will now be considered by Fortis’s shareholders for approval. And that is our Story of the Day. My name is Rakesh, and this Moneycontrol.

 
JM Financial Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
JM Financial Credit to raise up to Rs 2,000 cr via bonds

2018-05-10 moneycontrol
Wholesale finance non-banking financial company JM Financial Credit Solutions is looking to raise up to Rs 2,000 crore through its maiden bond issue, to fund growth and repay debt.

 
JM Financial Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
ReNew Power files IPO papers with SEBI

2018-05-09 thehindubusinessline
ReNew Power has filed draft papers with the Securities and Exchange Board of India to float an initial public offering.

 
India's ReNew Power files for IPO that could raise $1 bln

2018-05-08 reuters
MUMBAI (Reuters) - ReNew Power Ltd filed for an initial public offering on Tuesday that could raise more than $1 billion in one of India’s biggest listings so far this year.

 
JM Financial Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
PNB’s housing finance subsidiary recovers from Nirav Modi scam

2018-05-04 thehindubusinessline
After more than doubling (since its listing in November 2016) and hitting a 52-week high of ₹1,715 in August 2017, the stock of PNB Housing Finance was already in price correction mode by 2017-end and closed the year at ₹1,340 as valuation looked stretched.

 
PNB Housing Finance recovers from Nirav Modi scam that shook its parent

2018-05-04 thehindubusinessline
Our Bureau After more than doubling (since its listing in November 2016) and hitting a 52-week high of ₹1,715 in August 2017, the stock of PNB Housing Finance was already in price correction mode by 2017-end and closed the year at ₹1,340 as valuation looked stretched.

 
SEBI keeps HDFC AMC’s IPO in abeyance

2018-05-04 thehindubusinessline
HDFC AMC operates as a joint venture between Housing Development Finance Corporation and Standard Life Investments.

 
MOVES-Citigroup, JM Financial, TP ICAP, HSBC, Legal & General

2018-05-03 reuters
May 3 (Reuters) - The following financial services industry appointments were announced on Thursday. To inform us of other job changes, email [email protected]

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...